Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 166K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Heemskerk, M. H.M. Articles by Falkenburg, J.H. F. Search for Related Content PubMed PubMed Citation Articles by Heemskerk, M. H.M. Articles by Falkenburg, J.H. F. Social Bookmarking                            What's this?

Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, Netherlands

Address correspondence to Mirjam H.M. Heemskerk, Department of Hematology, Leiden University Medical Center, C2-R, P.O. Box 9600, 2300 RC Leiden, Netherlands. Phone: 31-71-5262271; Fax: 31-71-5266755; email: m.h.m.heemskerk{at}lumc.nl

T cells directed against minor histocompatibility antigens (mHags) might be responsible for eradication of hematological malignancies after allogeneic stem cell transplantation. We investigated whether transfer of T cell receptors (TCRs) directed against mHags, exclusively expressed on hematopoietic cells, could redirect virus-specific T cells toward antileukemic reactivity, without the loss of their original specificity. Generation of T cells with dual specificity may lead to survival of these TCR-transferred T cells for prolonged periods of time in vivo due to transactivation of the endogenous TCR of the tumor-reactive T cells by the latent presence of viral antigens. Furthermore, TCR transfer into restricted T cell populations, which are nonself reactive, will minimize the risk of autoimmunity. We demonstrate that cytomegalovirus (CMV)-specific T cells can be efficiently reprogrammed into leukemia-reactive T cells by transfer of TCRs directed against the mHag HA-2. HA-2-TCR–transferred CMV-specific T cells derived from human histocompatibility leukocyte antigen (HLA)-A2⁺ or HLA-A2^– individuals exerted potent antileukemic as well as CMV reactivity, without signs of anti–HLA-A2 alloreactivity. The dual specificity of these mHag-specific, TCR-redirected virus-specific T cells opens new possibilities for the treatment of hematological malignancies of HLA-A2⁺ HA-2–expressing patients transplanted with HLA-A2–matched or –mismatched donors.

Key Words: T cell receptor • gene transfer • minor histocompatibility antigen • virus-specific T cells • leukemia reactive

Abbreviations used in this paper: NGF-R, truncated form of the nerve growth factor receptor; CML, chronic myeloid leukemia; DLI, donor lymphocyte infusion; EBV-LCL, EBV-transformed B cell; eGFP, enhanced green fluorescent protein; HPC, hematopoietic progenitor cell; MFI, mean fluorescence intensity; mHag, minor histocompatibility antigen; MSC, mesenchymal stem cell; PHA, phytohemagglutinin; PIA, progenitor cell inhibition assay.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Schub, A., Schuster, I. G., Hammerschmidt, W., Moosmann, A. (2009). CMV-Specific TCR-Transgenic T Cells for Immunotherapy. J. Immunol. 183: 6819-6830 [Abstract] [Full Text]  
• Yvon, E., Del Vecchio, M., Savoldo, B., Hoyos, V., Dutour, A., Anichini, A., Dotti, G., Brenner, M. K. (2009). Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells. Clin. Cancer Res. 15: 5852-5860 [Abstract] [Full Text]  
• Griffioen, M., van Egmond, E. H.M., Kester, M. G.D., Willemze, R., Falkenburg, J.H. F., Heemskerk, M. H.M. (2009). Retroviral transfer of human CD20 as a suicide gene for adoptive T-cell therapy. haematol 94: 1316-1320 [Abstract] [Full Text]  
• van Loenen, M. M., Hagedoorn, R. S., Kester, M. G.D., Hoogeboom, M., Willemze, R., Falkenburg, J.H. F., Heemskerk, M. H.M. (2009). Kinetic Preservation of Dual Specificity of Coprogrammed Minor Histocompatibility Antigen-Reactive Virus-Specific T Cells. Cancer Res. 69: 2034-2041 [Abstract] [Full Text]  
• Smits, E. L.J.M., Berneman, Z. N., Van Tendeloo, V. F.I. (2009). Immunotherapy of Acute Myeloid Leukemia: Current Approaches. The Oncologist 14: 240-252 [Abstract] [Full Text]  
• van der Veken, L. T., Coccoris, M., Swart, E., Falkenburg, J. H. F., Schumacher, T. N., Heemskerk, M. H. M. (2009). {alpha}{beta} T Cell Receptor Transfer to {gamma}{delta} T Cells Generates Functional Effector Cells without Mixed TCR Dimers In Vivo. J. Immunol. 182: 164-170 [Abstract] [Full Text]  
• Griffioen, M., van Egmond, H.M. E., Barnby-Porritt, H., van der Hoorn, M. A.W.G., Hagedoorn, R. S., Kester, M. G.D., Schwabe, N., Willemze, R., Falkenburg, J.H. F., Heemskerk, M. H.M. (2008). Genetic engineering of virus-specific T cells with T-cell receptors recognizing minor histocompatibility antigens for clinical application. haematol 93: 1535-1543 [Abstract] [Full Text]  
• Thomas, S., Xue, S.-A., Cesco-Gaspere, M., San Jose, E., Hart, D. P., Wong, V., Debets, R., Alarcon, B., Morris, E., Stauss, H. J. (2007). Targeting the Wilms Tumor Antigen 1 by TCR Gene Transfer: TCR Variants Improve Tetramer Binding but Not the Function of Gene Modified Human T Cells. J. Immunol. 179: 5803-5810 [Abstract] [Full Text]  
• van Lent, A. U., Nagasawa, M., van Loenen, M. M., Schotte, R., Schumacher, T. N. M., Heemskerk, M. H. M., Spits, H., Legrand, N. (2007). Functional Human Antigen-Specific T Cells Produced In Vitro Using Retroviral T Cell Receptor Transfer into Hematopoietic Progenitors. J. Immunol. 179: 4959-4968 [Abstract] [Full Text]  
• Landmeier, S., Altvater, B., Pscherer, S., Eing, B. R., Kuehn, J., Rooney, C. M., Juergens, H., Rossig, C. (2007). Gene-Engineered Varicella-Zoster Virus Reactive CD4+ Cytotoxic T Cells Exert Tumor-Specific Effector Function. Cancer Res. 67: 8335-8343 [Abstract] [Full Text]  
• Spaapen, R., van den Oudenalder, K., Ivanov, R., Bloem, A., Lokhorst, H., Mutis, T. (2007). Rebuilding Human Leukocyte Antigen Class II-Restricted Minor Histocompatibility Antigen Specificity in Recall Antigen-Specific T Cells by Adoptive T Cell Receptor Transfer: Implications for Adoptive Immunotherapy. Clin. Cancer Res. 13: 4009-4015 [Abstract] [Full Text]  
• van Bergen, C. A. M., Kester, M. G. D., Jedema, I., Heemskerk, M. H. M., van Luxemburg-Heijs, S. A. P., Kloosterboer, F. M., Marijt, W. A. E., de Ru, A. H., Schaafsma, M. R., Willemze, R., van Veelen, P. A., Falkenburg, J. H. F. (2007). Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene. Blood 109: 4089-4096 [Abstract] [Full Text]  
• Biagi, E., Marin, V., Giordano Attianese, G. M. P., Dander, E., D'Amico, G., Biondi, A. (2007). Chimeric T-cell receptors: new challenges for targeted immunotherapy in hematologic malignancies. haematol 92: 381-388 [Abstract] [Full Text]  
• Heemskerk, M. H. M., Hagedoorn, R. S., van der Hoorn, M. A. W. G., van der Veken, L. T., Hoogeboom, M., Kester, M. G. D., Willemze, R., Falkenburg, J. H. F. (2007). Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex. Blood 109: 235-243 [Abstract] [Full Text]  
• van Leeuwen, E. M. M., Remmerswaal, E. B. M., Heemskerk, M. H. M., ten Berge, I. J. M., van Lier, R. A. W. (2006). Strong selection of virus-specific cytotoxic CD4+ T-cell clones during primary human cytomegalovirus infection. Blood 108: 3121-3127 [Abstract] [Full Text]  
• de Witte, M. A., Coccoris, M., Wolkers, M. C., van den Boom, M. D., Mesman, E. M., Song, J.-Y., van der Valk, M., Haanen, J. B. A. G., Schumacher, T. N. M. (2006). Targeting self-antigens through allogeneic TCR gene transfer. Blood 108: 870-877 [Abstract] [Full Text]  
• Schaft, N., Lankiewicz, B., Drexhage, J., Berrevoets, C., Moss, D. J., Levitsky, V., Bonneville, M., Lee, S. P., McMichael, A. J., Gratama, J.-W., Bolhuis, R. L. H., Willemsen, R., Debets, R. (2006). T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFN{gamma} production. Int Immunol 18: 591-601 [Abstract] [Full Text]  
• van der Veken, L. T., Hagedoorn, R. S., van Loenen, M. M., Willemze, R., Falkenburg, J.H. F., Heemskerk, M. H.M. (2006). {alpha}{beta} T-Cell Receptor Engineered {gamma}{delta} T Cells Mediate Effective Antileukemic Reactivity.. Cancer Res. 66: 3331-3337 [Abstract] [Full Text]  
• Duval, L., Schmidt, H., Kaltoft, K., Fode, K., Jensen, J. J., Sorensen, S. M., Nishimura, M. I., von der Maase, H. (2006). Adoptive Transfer of Allogeneic Cytotoxic T Lymphocytes Equipped with a HLA-A2 Restricted MART-1 T-Cell Receptor: A Phase I Trial in Metastatic Melanoma. Clin. Cancer Res. 12: 1229-1236 [Abstract] [Full Text]  
• Huang, X., Wilber, A. C., Bao, L., Tuong, D., Tolar, J., Orchard, P. J., Levine, B. L., June, C. H., McIvor, R. S., Blazar, B. R., Zhou, X. (2006). Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system. Blood 107: 483-491 [Abstract] [Full Text]  
• Chalandon, Y., Degermann, S., Villard, J., Arlettaz, L., Kaiser, L., Vischer, S., Walter, S., Heemskerk, M. H. M., van Lier, R. A. W., Helg, C., Chapuis, B., Roosnek, E. (2006). Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications. Blood 107: 389-396 [Abstract] [Full Text]  
• Kloosterboer, F. M., van Luxemburg-Heijs, S. A. P., van Soest, R. A., van Egmond, H. M. E., Willemze, R., Falkenburg, J. H. F. (2005). Up-regulated expression in nonhematopoietic tissues of the BCL2A1-derived minor histocompatibility antigens in response to inflammatory cytokines: relevance for allogeneic immunotherapy of leukemia. Blood 106: 3955-3957 [Abstract] [Full Text]  
• Xue, S.-A., Gao, L., Hart, D., Gillmore, R., Qasim, W., Thrasher, A., Apperley, J., Engels, B., Uckert, W., Morris, E., Stauss, H. (2005). Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells. Blood 106: 3062-3067 [Abstract] [Full Text]  
• Tsuji, T., Yasukawa, M., Matsuzaki, J., Ohkuri, T., Chamoto, K., Wakita, D., Azuma, T., Niiya, H., Miyoshi, H., Kuzushima, K., Oka, Y., Sugiyama, H., Ikeda, H., Nishimura, T. (2005). Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes. Blood 106: 470-476 [Abstract] [Full Text]  
• Morris, E. C., Tsallios, A., Bendle, G. M., Xue, S.-a., Stauss, H. J. (2005). A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection. Proc. Natl. Acad. Sci. USA 102: 7934-7939 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS